News from NORD

NCATS Unveils Toolkit for Patient-Focused Therapy Development

Publish date: May 7, 2018

 

The National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) has developed a new toolkit for the rare disease community to facilitate therapeutics research and development. Learn more about the toolkit here .

Recommended Reading

FDA approves burosumab to treat X-linked hypophosphatemia
MDedge Endocrinology
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Endocrinology
VIDEO: Few transgender patients desire care in a transgender-only clinic
MDedge Endocrinology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Endocrinology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Endocrinology
RFPs Available for the Study of Three Rare Diseases
MDedge Endocrinology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Endocrinology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Endocrinology
NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans
MDedge Endocrinology
Running for Rare Team Participates in Boston Marathon to Raise Funds for Undiagnosed Patients
MDedge Endocrinology